Arogya Sangama: 3 Way Partnership of People, Providers, and Panchayat for Health
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Jan 16, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Arogya Sangama trial is a two-year project taking place in the Raichur and Chamarajanagar districts of Karnataka, India. The goal of this trial is to improve how people use health services and to enhance the quality of care provided at new Health and Wellness Centres (HWCs). By working closely with local government groups, known as Gram Panchayat Task Forces, the project aims to empower communities to take charge of their health services. This means that residents, local leaders, and healthcare providers will work together to ensure that health services meet the needs of the community effectively.
To participate in this trial, you need to meet certain criteria. For women aged 18-49 who have given birth in the last year, and for individuals aged 30 and older who do not have diabetes or high blood pressure, you must live in the designated areas and speak Kannada. Participants can expect to be involved in activities that strengthen community health services and improve overall health knowledge and behaviors. This trial is important because it encourages local involvement in health care, aiming for better health outcomes for everyone in the community.
Gender
ALL
Eligibility criteria
- • Group 1 Inclusion criteria
- • 18-49 years of age women who delivered in the last 12 months
- • Residents of the districts and living within the service área covered by intervention and control PHC-HWCs
- • Kannada speaking
- • Able to provide consent
- • Group 2 inclusion criteria
- • 30 or more years of age
- • Not a known case of diabetes and hypertension
- • Residents of the districts and living within the service area covered by intervention and control PHC-HWCs
- • Kannada speaking
- • Able to provide consent
- Exclusion Criteria:
- • Group 1: women not in the age group 18-49 years of age
- • Group 2: participants younger than 30 years
- • Not residing in the service area covered by intervention and control PHC-HWCs
- • Unable to speak in Kannada
- • Unable to provide consent
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Devadurga, , India
Kollegal, , India
Patients applied
Trial Officials
Svea Closser, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported